Flebogamma® 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy.
| Autor: | Jorquera, J. I.1 juan.jorquera@grifols.com |
|---|---|
| Zdroj: | Clinical & Experimental Immunology. Sep2009 Supplement 1, Vol. 157, p17-21. 5p. 1 Color Photograph, 1 Diagram, 5 Charts, 1 Graph. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|